BIODESIX INC — Director's Dealing 2020

Nov 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-06-23

Reporting Person: PATIENCE JOHN (Director, 10% Owner, Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-30	Common Stock	C	1829368	—	Acquired	1829368	Indirect
2020-10-30	Common Stock	C	2501974	—	Acquired	2501974	Indirect
2020-10-30	Common Stock	C	245041	—	Acquired	2747015	Indirect
2020-10-30	Common Stock	C	81600	$14.40	Acquired	1910968	Indirect
2020-10-30	Common Stock	C	64416	$14.40	Acquired	2811431	Indirect
2020-10-30	Common Stock	P	30000	$18.00	Acquired	30000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-30	Series B Preferred Stock	$	C	1454545	Disposed		Common Stock (245042)	Indirect
2020-10-30	Series B-1 Preferred Stock	$	C	1250000	Disposed		Common Stock (245041)	Indirect
2020-10-30	Series C Preferred Stock	$	C	666666	Disposed		Common Stock (112311)	Indirect
2020-10-30	Series D Preferred Stock	$	C	250000	Disposed		Common Stock (42117)	Indirect
2020-10-30	Series D Preferred Stock	$	C	2932534	Disposed		Common Stock (494033)	Indirect
2020-10-30	Series E Preferred Stock	$	C	809200	Disposed		Common Stock (136323)	Indirect
2020-10-30	Series E Preferred Stock	$	C	1484624	Disposed		Common Stock (250109)	Indirect
2020-10-30	Series F Preferred Stock	$	C	3205681	Disposed		Common Stock (540050)	Indirect
2020-10-30	Series F Preferred Stock	$	C	3055837	Disposed		Common Stock (514806)	Indirect
2020-10-30	Series G Preferred Stock	$	C	957114	Disposed		Common Stock (161242)	Indirect
2020-10-30	Series G Preferred Stock	$	C	6711816	Disposed		Common Stock (1130715)	Indirect
2020-10-30	Series H Preferred Stock	$	C	4182413	Disposed		Common Stock (704596)	Indirect
2020-06-23	3% Convertible Debt due June 2021	$	A		Acquired	2021-06-30	Common Stock (10527)	Indirect
2020-10-30	3% Convertible Debt due June 2021	$14.40	C		Disposed	2021-06-30	Common Stock (81600)	Indirect
2020-10-30	3% Convertible Debt due June 2021	$14.40	C		Disposed	2021-06-30	Common Stock (64416)	Indirect

Footnotes

F1: Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the "Preferred Stock") converted into approximately 0.1684664 shares of Issuer Common Stock ("Common Stock") at the closing of the Issuer's initial public offering ("IPO"). Share numbers gave effect to such conversion. The Preferred Stock had no expiration date.

F2: The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F3: The reporting person is the sole trustee of John Patience Trust (July 23, 1993).

F4: Every share of Series B-1 Preferred Stock ("B-1 Preferred Stock") converted into approximately 0.196 shares of Common Stock at the closing of the Issuer's IPO. Share numbers gave effect to such conversion. The B-1 Preferred Stock had no expiration date.

F5: This Convertible Debt paid interest at 3% per annum and was payable in full upon maturity through the conversion to Series H Preferred Stock at 80% of the original issuance price of $1.15 per share. On or before the maturity date and if the Convertible Debt remained unpaid, the outstanding principal and unpaid accrued interest was to be automatically converted into Common Stock at the completion of the IPO at a conversion price equal to 80% of the price per share paid for the Common Stock sold in the IPO. Share numbers give effect to such conversion; debt amount reflects principal only, no interest.

F6: This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.

F7: Upon completion of the IPO, the outstanding principal and unpaid accrued interest on this Convertible Debt was automatically converted into Common Stock. Share numbers gave effect to such conversion; debt amount reflects principal only, no interest.